Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Malaria has been the pre-eminent cause of early mortality in many parts of the world throughout much of the last five thousand years and, as a result, it is the strongest force for selective pressure on the human genome yet described. Around one third of the variability in the risk of severe and complicated malaria is now explained by additive host genetic effects. Many individual variants have been identified that are associated with malaria protection, but the most important all relate to the structure or function of red blood cells. They include the classical polymorphisms that cause sickle cell trait, α-thalassaemia, G6PD deficiency, and the major red cell blood group variants. More recently however, with improving technology and experimental design, others have been identified that include the Dantu blood group variant, polymorphisms in the red cell membrane protein ATP2B4, and several variants related to the immune response. Characterising how these genes confer their effects could eventually inform novel therapeutic approaches to combat malaria. Nevertheless, all together, only a small proportion of the heritable component of malaria resistance can be explained by the variants described so far, underscoring its complex genetic architecture and the need for continued research.

Original publication

DOI

10.1007/s00439-020-02142-6

Type

Journal

Human genetics

Publication Date

06/2020

Volume

139

Pages

801 - 811

Addresses

Department of Epidemiology, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya. SNKariuki@kemri-wellcome.org.

Keywords

Erythrocytes, Humans, Plasmodium, Malaria, Genetics, Population, Polymorphism, Genetic, Genome, Human, Host-Parasite Interactions, Disease Resistance, Human Genetics